Drug
Bcs Srg 514
Bcs Srg 514: highest development phase Phase 3, developed by SURGE Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- SURGE Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BCS + SRG-514 NCT07723469 | Phase 3 | TNBC - Triple-Negative Breast Cancer |
Latest
No recent events.
Follow Bcs Srg 514 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.